AU Patent

AU2021305214A1 — Lipid nanoparticles for delivering therapeutics to lungs

Assigned to Genevant Sciences GmbH · Expires 2023-02-23 · 3y expired

What this patent protects

Certain embodiments of the invention provide lipid nanoparticles for delivery nucleic acid therapeutics to the lungs.

USPTO Abstract

Certain embodiments of the invention provide lipid nanoparticles for delivery nucleic acid therapeutics to the lungs.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021305214A1
Jurisdiction
AU
Classification
—
Expires
2023-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Genevant Sciences GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.